Literature DB >> 14664135

Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction.

Olaf Grebe1, Ingo Paetsch, Hans A Kestler, Bernhard Herkommer, Bernhard Schnackenburg, Vinzenz Hombach, Eckart Fleck, Eike Nagel.   

Abstract

The aim of this study was to simplify the imaging of myocardial infarction based on theoretical aspects and patient variables and to define the optimal time for image acquisition. Thirteen patients with chronic myocardial infarction underwent magnetic resonance imaging. After injection of 0.2 mmol/kg body weight Gd-DTPA an inversion recovery turbo gradient echo sequence with different prepulse delays was applied every 3 to 5 minutes within an interval of 3 to 30 minutes. As parameters of investigation, the area of signal enhancement and the contrast between enhanced and nonenhanced myocardium were used. There was no influence of prepulse delay or time after contrast injection on the enhanced area. The contrast between enhanced and normal myocardium showed a peak at 6 minutes post Gd-DTPA injection and remained high. The contrast between blood and enhanced myocardium was best at 6 and 25 minutes with best intra- and interobserver variability. In conclusion, if a suitable contrast was achieved, the area of enhancement is independent of prepulse delay or imaging time. In most patients the highest contrast between blood, enhanced and normal myocardium is achieved 6 minutes and 25 minutes after contrast injection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14664135     DOI: 10.1081/jcmr-120025231

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  9 in total

1.  Determination of location, size, and transmurality of chronic myocardial infarction without exogenous contrast media by using cardiac magnetic resonance imaging at 3 T.

Authors:  Avinash Kali; Ivan Cokic; Richard L Q Tang; Hsin-Jung Yang; Behzad Sharif; Eduardo Marbán; Debiao Li; Daniel S Berman; Rohan Dharmakumar
Journal:  Circ Cardiovasc Imaging       Date:  2014-03-28       Impact factor: 7.792

2.  T1 mapping using saturation recovery single-shot acquisition at 3-tesla magnetic resonance imaging in hypertrophic cardiomyopathy: comparison to late gadolinium enhancement.

Authors:  Ryo Ogawa; Tomoyuki Kido; Masashi Nakamura; Teruhito Kido; Akira Kurata; Teruyoshi Uetani; Akiyoshi Ogimoto; Masao Miyagawa; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2017-01-19       Impact factor: 2.374

3.  Contrast-enhanced adenosine-stress magnetic resonance imaging--feasibility and practicability of a protocol for detection or exclusion of ischemic heart disease in an outpatient setting.

Authors:  P Bernhardt; B Levenson; T Engels; O Strohm
Journal:  Clin Res Cardiol       Date:  2006-07-14       Impact factor: 5.460

4.  Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction.

Authors:  André Schmidt; Clerio F Azevedo; Alan Cheng; Sandeep N Gupta; David A Bluemke; Thomas K Foo; Gary Gerstenblith; Robert G Weiss; Eduardo Marbán; Gordon F Tomaselli; João A C Lima; Katherine C Wu
Journal:  Circulation       Date:  2007-03-26       Impact factor: 29.690

5.  Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up.

Authors:  Peter Bernhardt; Sascha Stiller; Eva Kottmair; Ludwig Binner; Jochen Spiess; Georg Grossmann; Volker Rasche; Daniel Walcher; Vinzenz Hombach
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-19       Impact factor: 2.357

6.  3D whole-heart grey-blood late gadolinium enhancement cardiovascular magnetic resonance imaging.

Authors:  Claudia Prieto; René M Botnar; Giorgia Milotta; Camila Munoz; Karl P Kunze; Radhouene Neji; Stefano Figliozzi; Amedeo Chiribiri; Reza Hajhosseiny; Pier Giorgio Masci
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-24       Impact factor: 5.364

7.  Visualization of chronic myocardial infarction using the intravascular contrast agent MS-325 (gadofosveset) in patients.

Authors:  Thomas Thouet; Bernhard Schnackenburg; Thomas Kokocinski; Eckart Fleck; Eike Nagel; Sebastian Kelle
Journal:  ScientificWorldJournal       Date:  2012-03-12

8.  Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.

Authors:  John Stirrat; Sebastien Xavier Joncas; Michael Salerno; Maria Drangova; James White
Journal:  J Cardiovasc Magn Reson       Date:  2015-08-07       Impact factor: 5.364

9.  High-throughput gadobutrol-enhanced CMR: a time and dose optimization study.

Authors:  Tommaso D'Angelo; Chrysanthos Grigoratos; Silvio Mazziotti; Konstantinos Bratis; Faraz Pathan; Alfredo Blandino; Elen Elen; Valentina O Puntmann; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2017-11-06       Impact factor: 5.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.